Merit Medical Systems, Inc. $MMSI Shares Sold by Handelsbanken Fonder AB

Handelsbanken Fonder AB trimmed its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 16.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 268,309 shares of the medical instruments supplier’s stock after selling 53,000 shares during the quarter. Handelsbanken Fonder AB’s holdings in Merit Medical Systems were worth $23,649,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Maseco LLP acquired a new stake in Merit Medical Systems in the 4th quarter valued at about $26,000. Torren Management LLC purchased a new stake in shares of Merit Medical Systems during the fourth quarter valued at $38,000. Danske Bank A S purchased a new stake in shares of Merit Medical Systems during the third quarter valued at $42,000. Quarry LP lifted its holdings in shares of Merit Medical Systems by 185.9% during the third quarter. Quarry LP now owns 526 shares of the medical instruments supplier’s stock valued at $44,000 after purchasing an additional 342 shares during the last quarter. Finally, Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Merit Medical Systems during the fourth quarter valued at $47,000. 99.66% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

MMSI has been the subject of several analyst reports. JPMorgan Chase & Co. reduced their target price on Merit Medical Systems from $95.00 to $77.00 and set an “overweight” rating for the company in a report on Friday, May 1st. Needham & Company LLC reduced their target price on Merit Medical Systems from $101.00 to $90.00 and set a “buy” rating for the company in a report on Friday, May 1st. Canaccord Genuity Group reduced their target price on Merit Medical Systems from $90.00 to $85.00 and set a “buy” rating for the company in a report on Friday, May 1st. Weiss Ratings downgraded Merit Medical Systems from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, May 8th. Finally, Wells Fargo & Company reduced their target price on Merit Medical Systems from $78.00 to $74.00 and set an “equal weight” rating for the company in a report on Friday, May 1st. Eight research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Merit Medical Systems has a consensus rating of “Moderate Buy” and an average price target of $92.80.

Merit Medical Systems Trading Up 1.1%

Shares of NASDAQ MMSI opened at $64.49 on Thursday. Merit Medical Systems, Inc. has a one year low of $59.74 and a one year high of $100.05. The firm has a market capitalization of $3.85 billion, a PE ratio of 27.92, a PEG ratio of 1.99 and a beta of 0.58. The company has a current ratio of 5.08, a quick ratio of 3.46 and a debt-to-equity ratio of 0.45. The business has a 50-day moving average price of $67.10 and a two-hundred day moving average price of $78.05.

Merit Medical Systems (NASDAQ:MMSI) last announced its quarterly earnings data on Thursday, April 30th. The medical instruments supplier reported $0.94 EPS for the quarter, topping analysts’ consensus estimates of $0.84 by $0.10. Merit Medical Systems had a return on equity of 13.54% and a net margin of 9.03%.The firm had revenue of $381.88 million during the quarter, compared to analyst estimates of $377.59 million. During the same period last year, the company posted $0.86 EPS. The business’s quarterly revenue was up 7.4% compared to the same quarter last year. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. As a group, analysts predict that Merit Medical Systems, Inc. will post 3.61 earnings per share for the current fiscal year.

Insider Activity at Merit Medical Systems

In related news, insider Brian G. Lloyd acquired 2,000 shares of the company’s stock in a transaction on Thursday, May 7th. The shares were purchased at an average price of $62.62 per share, for a total transaction of $125,240.00. Following the purchase, the insider owned 2,000 shares in the company, valued at $125,240. This represents a ∞ increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Lynne N. Ward sold 5,000 shares of the company’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $62.61, for a total transaction of $313,050.00. Following the completion of the transaction, the director owned 7,809 shares in the company, valued at approximately $488,921.49. This represents a 39.04% decrease in their position. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by corporate insiders.

Merit Medical Systems Company Profile

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.